MedTrace Logo

Ultrasound Guided Local Anesthetic Block: Thoracolumbar Interfascial Plane

NCT02297191 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2018-06-20

No results posted yet for this study

Summary

The purpose of the study is to determine the effectiveness of a new approach to numbing (anesthetizing) nerves in the back and to measure how far the area of anesthesia extends on the skin of the back.

Conditions

  • Healthy

Interventions

PROCEDURE

Thoracolumbar Interfascial Plane Block

All participants will have two injections at the same vertebral level on each side of the back. Each injection will consist of four 5cc incremental injections with aspiration prior to each 5cc of injectate of 0.5% Ropivicaine. . Each side of the back will be injected with 20cc of .05% Ropivicaine. Ultrasound will be used in real time to guide the needle. 1. Ultrasound images will be saved using the nomenclature TLIP Anatomy 2. Photos will only include surface anatomy of the low-to-mid back. 3. Participants will be assessed for evidence of adverse reaction to local anesthesia (tinnitus, disorientation, or perioral numbness) with each 5cc dose of local anesthetic. If any adverse reactions are noted the dosing will be stopped.

DRUG

Ropivicaine

Sponsors & Collaborators

  • Medical University of South Carolina

    lead OTHER

Principal Investigators

  • William Hand, MD · Medical University of South Carolina

  • Scott T Reeves, MD · Medical University of South Carolina

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2014-11-30
Completion
2014-11-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02297191 on ClinicalTrials.gov